NIH-funded research Fellowship grant

Gene therapy to restore fertility in males with Sertoli cell dysfunction

Official title: AAV gene therapy to restore fertility in mammalian Sertoli cell dysfunction models

Funded at Magee-Women's Res Inst and Foundation · NIH-11055962 · Data updated 2026-11-12

This study is looking at a new gene therapy using a virus to help treat male infertility caused by problems with Sertoli cells, specifically for men who have a condition called non-obstructive azoospermia, and it aims to find a safe and effective way to restore sperm production.

More Fertility research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionMagee-Women's Res Inst and Foundation
NIH-funded
Lab location1 site (Pittsburgh, UNITED STATES)
Project startMarch 1, 2024
Project endFebruary 28, 2027
Funding year2025
Award (this year)$48,974
NIH project number5F31HD114406-02
Project IDNIH-11055962 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are males diagnosed with non-obstructive azoospermia, particularly those with identified genetic causes.

Less likely to help

Patients with infertility due to obstructive causes or other non-genetic factors may not benefit from this research.

What this research studies

This research investigates the use of adeno-associated virus (AAV) gene therapy to treat male infertility caused by Sertoli cell dysfunction, specifically in cases of non-obstructive azoospermia (NOA). The approach involves testing the safety and effectiveness of delivering a corrective gene to Sertoli cells in mouse models that mimic human conditions. By focusing on the genetic causes of infertility, the research aims to develop a potential treatment that could restore sperm production. The study addresses ethical considerations regarding germline modifications and aims to ensure that any therapeutic interventions are safe and effective.

Why it matters

Potential benefit: If successful, this research could provide a novel treatment option for men suffering from infertility due to Sertoli cell dysfunction.

How similar studies have gone: Previous research has shown promise in using AAV gene therapy for similar applications, indicating potential for success in this novel approach.

Where this research is happening

  • Magee-Women's Res Inst and Foundation
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Atkins, Georgia Rae — Magee-Women's Res Inst and Foundation
  • Study coordinator: Atkins, Georgia Rae

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.